A Nottingham-based company developing a range of orthobiologics has raised £10m through a series A funding round.

The investment into Locate Bio consists of a direct investment from Mercia Asset Management of £1.6m, alongside £4m from Mercia’s third party managed funds, which included EIS and VCT capital, together with £3m from BGF and £1.4m from other syndicate partners.

Click here to read the full article 

GET IN TOUCH!


  MAIL US
enquiries@growthinvest.com

  CALL US
020 7071 3945

FOLLOW US ON


Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.